Lemtrada Dosage
Generic name: Alemtuzumab (Lemtrada)
Drug class: CD52 monoclonal antibodies
Medically reviewed by A Ras MD.
Recommended Adult Dosing
Dosage forms: INJ
Restricted Distribution in US
Multiple sclerosis, relapsing forms
- [1st course]
- Dose: 12 mg IV qd x5 days; Info: for pts w/ relapsing-remitting dz and active secondary progressive dz; not recommended for pts w/ clinically isolated syndrome; see pkg insert for premeds and prophylaxis
- [2nd course]
- Dose: 12 mg IV qd x3 days; Start: 12mo after 1st course; Info: for pts w/ relapsing-remitting dz and active secondary progressive dz; not recommended for pts w/ clinically isolated syndrome; see pkg insert for premeds and prophylaxis
- [subsequent courses]
- Dose: 12 mg IV qd x3 days; Start: as needed at least 12mo after last course; Info: for pts w/ relapsing-remitting dz and active secondary progressive dz; not recommended for pts w/ clinically isolated syndrome; see pkg insert for premeds and prophylaxis
Renal dosing
- [not defined]
- renal impairment: not defined
- HD/PD: not defined
Hepatic dosing
- [not defined]
SRC: NLM .